Literature DB >> 1512604

Second European Stroke Prevention Study. ESPS-2 Working Group.

.   

Abstract

The computerized design, aims, organization, and structure of the European Stroke Prevention Study 2 (ESPS-2) are presented. This clinical trial will investigate the effect of single and combination regimens of low-dose acetylsalicylic acid (50 mg daily) and dipyridamole (400 mg daily) versus placebo in secondary prevention of stroke and death.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1512604     DOI： 10.1007/bf00867583

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  2 in total

1.  European Stroke Prevention Study. ESPS Group.

Authors: 
Journal:  Stroke       Date:  1990-08       Impact factor: 7.914

2.  The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group.

Authors: 
Journal:  Lancet       Date:  1987-12-12       Impact factor: 79.321
  2 in total
  7 in total

1.  Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.

Authors:  D Praticò; C Tillmann; Z B Zhang; H Li; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

Review 2.  Platelet aggregation inhibitors in neurology.

Authors:  A Keyser
Journal:  Pharm World Sci       Date:  1993-12-17

3.  Antithrombotic Secondary Prevention After Stroke.

Authors:  Hans-Christoph Diener; Peter Ringleb
Journal:  Curr Treat Options Neurol       Date:  2001-09       Impact factor: 3.598

Review 4.  Plasminogen activators and ischemic stroke: conditions for acute delivery.

Authors:  Gregory J del Zoppo
Journal:  Semin Thromb Hemost       Date:  2013-03-28       Impact factor: 4.180

5.  Antithrombotic Secondary Prevention After Stroke.

Authors:  Hans-Christoph Diener; Peter Ringleb
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-10

6.  Stroke management.

Authors:  Kameshwar Prasad; Subhash Kaul; M V Padma; S P Gorthi; Dheeraj Khurana; Asha Bakshi
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

Review 7.  Antiplatelet Use in Ischemic Stroke.

Authors:  Marharyta Kamarova; Sheharyar Baig; Hamish Patel; Kimberley Monks; Mohammed Wasay; Ali Ali; Jessica Redgrave; Arshad Majid; Simon M Bell
Journal:  Ann Pharmacother       Date:  2022-01-29       Impact factor: 3.463
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.